| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.003 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.003 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.099 | 0.003 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.003 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.004 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.004 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.44 | 0.004 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.004 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.004 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.09 | 0.004 |